Navigation Links
Elk Run Developers Announce Partnership with Leading Life Sciences Firm
Date:3/12/2009

Tower Investments, LLC, and Burrill & Company Collaborating on Strategic Next Steps for BioBusiness Development

PINE ISLAND, Minn., March 12 /PRNewswire/ -- Developer Tower Investments, LLC ("Tower"), and San Francisco-based life sciences firm Burrill & Company ("Burrill") today announced a formal partnership with aims of advancing plans for the Elk Run master planned development and funding related to the "shovel-ready" BioBusiness Park at Elk Run.

Tower and Burrill have partnered to support the 2,325-acre (941 hectare) development in Pine Island, Minnesota. The team is also addressing--in addition to the real estate project--a private equity/venture capital fund to support development of new technologies emanating from Mayo Clinic, the University of Minnesota and private entities, and to attract biotech/biomedical business to the state of Minnesota and Elk Run.

"Working with a world-class firm like Burrill brings to Elk Run capital, experience, innovation and opportunity that will be transformative for the region," said Tower founder and CEO, Stephen Marks, Sr.

Burrill, led by founder and CEO G. Steven Burrill, brings to the table an exclusive focus and expertise in the life sciences, with activities in private equity, venture capital, merchant banking and media and nearly $1B under management.

"Elk Run is geographically and strategically positioned in a uniquely propitious way," said Burrill. "The opportunity to work with Tower on this enterprise is exciting for us especially considering Elk Run's proximity to Rochester, home of Mayo Clinic, and its incredible potential to create and attract bioscience companies to the State.

"We recognize that, at a time of economic dislocation around the world, investing in innovative life science companies and attracting these companies to the region will create jobs and ultimately improve patient
'/>"/>

SOURCE Burrill & Company; Tower Investments, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. Spectral announces 2008 financial results
4. Advance Nanotechs Owlstone Announces First Pharmaceutical Industry Order
5. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
6. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results Conference Call
7. SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
8. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
9. Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12
10. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
11. Mach One Announces Appointment of Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Israel , July 25, 2014  Galmed Pharmaceuticals ... biopharmaceutical company focused on the development and commercialization of ... diseases and cholesterol gallstones, today announced financial results for ... Half 2014 Financial Summary: , Reported cash and ... compared with $137,000 at December 31, 2013.  , ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today ... a presentation to investors on Tuesday, July 29, ...  The presentation will include an overview of Asterias, ... the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least ...
(Date:7/24/2014)... Quantum computers have yet to materialise. Yet, scientists ... making such computers faster. One such approach relies ... controlled by applying an electric field. A new ... coherently coupled quantum dots (TQDs) with electrical impulses ... for example, should TQDs be used as quantum ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... Inc. (Nasdaq: IDEV ) announced today the ... entitled "Once Daily Dosage Forms,of Trospium," which is ... Supernus Pharmaceuticals, Inc., The ,978 patent covers ... of trospium chloride which is indicated for the,treatment ...
... BRUNSWICK, N.J., Aug. 13 At the upcoming ... R&D Team,Leader, will present "Silicone Elastomer Gels: New ... place in Philadelphia, September 16-17., According to ... molecular,structures that provide differentiated performance features for wound ...
... - Test Cleared to Screen Donated Blood for Hepatitis ... C, on Fully and Semi-Automated Instrument Systems -, ... ) announced today that the US Food and Drug ... the,PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the ...
Cached Biology Technology:Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM) 2Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM) 3Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference 2FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4
(Date:7/24/2014)... electric cars ply silent freeways, solar panels blanket rooftops ... earth, from howling winds and from the blazing desert ... is technically and economically feasible to convert California,s all-purpose ... Published in Energy , the plan shows the ... in California that could create tens of thousands of ...
(Date:7/24/2014)... has its own microbial terroir, meaning the microbial populations ... in the product, creating the final flavor according to ... Applied and Environmental Microbiology . This is the first ... sake brewery. , Many sake makers inoculate with ... Mills of the University of California, Davis, but he ...
(Date:7/24/2014)... low vision specialist at The University of Texas Health ... awarded a grant to help Harris County residents whose ... surgery. , Even with corrective lenses, many people with ... are a variety of low vision devices, such as ... vision loss. , Iyer is using the three-year, $164,645 ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4The microbes make the sake brewery 2UTHealth Dr. Bhavani Iyer awarded low vision grant 2
... Vascular and Interventional Radiology ,s impact factorthe measure of ... of article citations compared to the total number of ... journal,s quality and influence has remained consistently high over ... been enhanced recently by the increased use of new ...
... A University of Colorado School of Medicine scientist is ... could boost cognitive function in those with Down syndrome, ... potential milestone in research on this genetic condition. ... those with Down syndrome," said Alberto Costa, MD, PhD, ...
... with over half with a depth greater than 3000 ... know that the deep ocean contains a diversity of ... biological and mineral resources. Human activities are, however increasingly ... loss and, with this, the loss of many goods ...
Cached Biology News:Journal of Vascular and Interventional Radiology increases impact, offers new initiatives 2Journal of Vascular and Interventional Radiology increases impact, offers new initiatives 3Researcher tests promising drug on those with Down syndrome 2Man and the last great wilderness: Human impact on the deep sea 2Man and the last great wilderness: Human impact on the deep sea 3Man and the last great wilderness: Human impact on the deep sea 4
Lipid Phosphate Phosphohydrolase 2...
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
ANTI-HUMAN CYTOKINES, GROWTH FACTORS (polyclonal rabbit (or goat) antibodies) Human TARC - Biotin...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Biology Products: